Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

Tata Motors leads Nifty 100 companies in R&D spending, focusing on mobility solutions and alternative fuel technologies.

Pankaj Patel discusses the need for innovation in pharmaceutical research and the upcoming incentive policy in India.

PRIP aims to transform India into a global powerhouse for R&D in the pharma and MedTech sector, with a total financial outlay of ₹5,000 crore – made up of two components. The first component ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

R&amp,D outsourcing involves pharmaceutical companies subcontracting parts of their R&amp,D efforts to third-party service providers. Small or mid-sized pharmaceutical or biotech houses may use ...

set up a pharmaceutical business in 1876. He was a pioneer of new methods in the industry, being one of the first to focus on R&D as well as manufacturing. Another military man in the drugs ...

The Department of Pharmaceuticals has invited expressions of interest for project funding under the PRIP scheme, aiming to transform India into a global R&D hub in the Pharma MedTech sector.

Finnish drugmaker Orion Corporation has announced that it is establishing a new research and development (R&D) center in Cambridge, UK, during 2025 to accelerate its global growth strategy and the ...

Our Bureau, New Delhi Monday, March 10, 2025, 17:10 Hrs [IST] The Department of Pharmaceuticals (DoP) has released the Expre ...

But much will depend on how quickly and effectively the funds are deployed, if regulatory bottlenecks are eased, and how actively private players participate. India is making a push to move beyond ...